The Oxford Vaccine Group is currently inviting healthy children aged 13 – 48 months to take part in a swabbing study looking at how much pneumococcal bacteria is carried in the nose.
Streptococcus pneumoniae is a type of bacteria that is carried (lives) in the nose of most individuals at some time in their lives and can sometimes go on to cause severe infections such as meningitis and pneumonia. There are over 100 types of pneumococcus and children in the UK have been routinely immunised against pneumococcal disease since 2006.
In this study the Oxford Vaccine Group wish to get a better understanding of the how the pneumococcal vaccine affects nasal carriage in children who have been vaccinated.
The study is open for children aged 13 to 48 months who have received all three doses of their pneumococcal vaccine according to the routine schedule.
The study consists of one visit, during which your child would have a single nasal swab collected and the option to provide a finger-prick blood sample (only for the first *** participants who volunteer for it). The study visit would be conducted at a central location and time convenient to you. Participation in the study is voluntary and your child may withdraw from the study at any time.
If you are interested in participating in the study, it is important that you read the study information booklet (hyperlink).
If you would like to register to participate, please fill in the eligibility questions below. It is important for you to know that all answers are anonymous and kept completely confidential.
If you would like to discuss any aspect of the study please contact us on:
Tel: 01865 611400 or